Ogura Y, Lala S, Xin W, Smith E, Dowds T A, Chen F F, Zimmermann E, Tretiakova M, Cho J H, Hart J, Greenson J K, Keshav S, Nuñez G
Department of Pathology and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
Gut. 2003 Nov;52(11):1591-7. doi: 10.1136/gut.52.11.1591.
Genetic variation in NOD2 has been associated with susceptibility to Crohn's disease (CD) and specifically with ileal involvement. The reason for the unique association of NOD2 mutations with ileal disease is unclear. To identify a possible link, we tested expression of NOD2 in intestinal tissue of CD patients and controls.
Fifty five specimens of ileum or colon from 21 CD patients, seven ulcerative colitis (UC) patients, and five controls with pathology other than CD or UC were stained for NOD2 using an immunoperoxidase method.
Using a monoclonal antibody against NOD2 developed in our laboratory, we detected uniform expression of NOD2 in terminal ileum Paneth cells from controls and patients as well as in metaplastic Paneth cells in the colon. Mechanical purification showed enriched expression of NOD2 mRNA in ileal crypts. In Paneth cells, NOD2 was located in the cytosol in close proximity to the granules that contain antimicrobial peptides. We detected minimal NOD2 in the villous epithelium of the ileum or in the colonic epithelium from both CD patients and controls.
These results suggest a role for NOD2 in the regulation of Paneth cell mediated responses against intestinal bacteria and a plausible mechanism to explain the selective association of NOD2 mutations with ileal disease. The impaired capacity of CD associated mutations to sense luminal bacteria may result in increased susceptibility to certain gut microbes.
NOD2基因变异与克罗恩病(CD)易感性相关,尤其与回肠受累有关。NOD2突变与回肠疾病独特关联的原因尚不清楚。为确定可能的联系,我们检测了CD患者和对照者肠道组织中NOD2的表达。
使用免疫过氧化物酶法,对21例CD患者、7例溃疡性结肠炎(UC)患者以及5例患有非CD或UC的其他病理疾病的对照者的55份回肠或结肠标本进行NOD2染色。
使用我们实验室研发的针对NOD2的单克隆抗体,我们在对照者和患者的回肠末端潘氏细胞以及结肠化生的潘氏细胞中检测到NOD2的均匀表达。机械纯化显示回肠隐窝中NOD2 mRNA表达富集。在潘氏细胞中,NOD2位于靠近含有抗菌肽的颗粒的胞质溶胶中。我们在CD患者和对照者的回肠绒毛上皮或结肠上皮中检测到极少的NOD2。
这些结果提示NOD2在调节潘氏细胞介导的针对肠道细菌的反应中起作用,并且为解释NOD2突变与回肠疾病的选择性关联提供了一个合理的机制。与CD相关的突变感知肠腔细菌的能力受损可能导致对某些肠道微生物的易感性增加。